drugset / Trial / NCT05849558
Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to compare the efficacy \& safety of Ursoplus® capsules (UDCA 250mg \& Silymarin 140mg) versus UDCA alone versus Placebo among Compensated Chronic Liver Diseased Patients
Timeline
- Start
- 2022-02-22
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Silymarin | Traditional medicine (herbal / TCM) | 140 mg | — |
| Comparator | Ursodeoxycholic Acid | Small molecule | 250 mg | — |